StudyFinder



Clear

Search Results

Here are the studies that match your search criteria. If you are interested in participating, please reach out to the contact listed for the study. If no contact is listed, contact us and we'll help you find the right person.

1 Study Matches

Site for An Open-label Multiple Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Upadaticinib in Pediatric Subjects with Severe Atopic Dermatitis

Phase 1, multiple-dose, open-label study consisting of two parts, male and female subjects aged 2 to 12 years with severe atopic dermatitis (eczema).

Andrea Zaenglein
Samantha Gettle - at sgettle2@pennstatehealth.psu.edu or 717-531-5136
 

All
Younger than 18 years old
This study is NOT accepting healthy volunteers
NCT03646604
SITE00000468
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
must weight 22 pounds or more
Have a diagnosis of Atopic Dermatitis for at least 6 months
Exclusion Criteria:
Certain treatments are not allowed; coordinator will discuss specific treatments
No active Hep A, Hep C or Hep B
Current participation in another clinical trial
Skin Conditions
I'm interested
Share via email
See this study on ClinicalTrials.gov
Show 1 location

Study Locations

Hide all locations
Location Contacts
Hershey, PA ,